Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published May 1, 1981 | public
Journal Article Open

Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line

Abstract

We examined 14 different feline leukemia virus proviruses from the productively infected human cell line RD(FeLV)-2 after cloning in the modified lambda vector Charon 4A. Each isolate was characterized by restriction digestion and Southern blot analysis. The DNA of each isolate was tested for competence to express virus after uptake by sensitive animal cells (transfection). All but one isolate contained an apparently complete provirus, but only four were infectious. Seven isolates (four noninfectious, three infectious) were studied by heteroduplexing followed by electron microscopy or by S1 nuclease treatment and gel electrophoresis. No regions of nonhomology between proviruses were detected by either criterion, and in no case did we observe homology between flanking sequences. Random shearing or removal of flanking sequences by S1 nuclease had no effect on the status of infectivity of the clones. Thus, we were unable to find molecular differences between infectious and noninfectious proviruses. Our data are consistent with either of the following hypotheses: (i) that there is a short host sequence which is essential as a promoter for virus expression; or (ii) that lack of infectivity is due to small mutations within the proviral genome.

Additional Information

Copyright © 1981 by the American Society for Microbiology. Received 12 November 1980/Accepted 19 January 1981 We thank Marie Krempin for expert technical assistance, R. V. Gilden and co-workers for conducting the complement fixation tests, E. Fritsch for providing the Alu family probe, and E. Fritsch, T. Sargent, D. Goldberg, and R. Parker for suggestions. We are grateful to O. Jarrett and his co-workers for determining the subgroup of the FeLV produced by transfection. J.I.M. was a postdoctoral fellow of the American Cancer Society and is a postdoctoral fellow of the National Institutes of Health. K.B.B. is a postdoctoral fellow of the National Institutes of Health. This work was supported by Public Health Service grants CA 29199 to M.O.N. and CA 25991 to N.D. from the National Institutes of Health.

Files

MULjvir81.pdf
Files (3.5 MB)
Name Size Download all
md5:974be8e2b545d75f70da5a414c721c43
3.5 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 13, 2023